Imedex

Imedex is a premier global provider of accredited medical education (CME) and healthcare communications services, primarily serving the pharmaceutical and biotechnology industries. The company specializes in the development and execution of high-level scientific congresses, symposia, and digital educational programs, with a core focus on oncology, hematology, and gastroenterology. Imedex is widely recognized for organizing major international events, most notably the World Congress on Gastrointestinal Cancer. In 2017, the company was acquired by HMP Global, integrating its extensive portfolio of clinical meetings into HMP's broader healthcare events and education platform. Imedex's mission is to improve patient care by providing healthcare professionals with the most current clinical evidence and best practices through independent medical education.